Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Super-Affinity Antibody

InVivoMAb Anti-Human PRLR Antibody (Iv0132)

Catalog #:   VHD18001 Specific References (50) DATASHEET
Host species: Human
Isotype: IgG2, lambda
Applications: ELISA, Neutralization
Accession: P16471
Overview

Catalog No.

VHD18001

Species reactivity

Human

Host species

Human

Isotype

IgG2, lambda

Clonality

Monoclonal

Target

PRLR, PRL-R, Prolactin receptor

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P16471

Applications

ELISA, Neutralization

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

Iv0132

Data Image
References

A prolactin-targeting antibody to prevent stress-induced peripheral nociceptor sensitization and female postoperative pain., PMID:40354542

Prolactin maintains the neonatal phenotype of enterocytes during lactation in newborn mice., PMID:40353577

Production and Functional Verification of 8-Gene (GGTA1, CMAH, β4GalNT2, hCD46, hCD55, hCD59, hTBM, hCD39)-Edited Donor Pigs for Xenotransplantation., PMID:40190036

Immunization with OPN5 increased seasonal degradation of reproductive activity in Magang ganders., PMID:39754930

Does the brain make prolactin?, PMID:39041379

The immunotoxin targeting PRLR increases tamoxifen sensitivity and enhances the efficacy of chemotherapy in breast cancer., PMID:38898487

A precise molecular subtyping of ulcerative colitis reveals the immune heterogeneity and predicts clinical drug responses., PMID:37443022

Prolactin and oxytocin: potential targets for migraine treatment., PMID:36967387

Prolactin receptor signaling: A novel target for cancer treatment - Exploring anti-PRLR signaling strategies., PMID:36714582

Isolation of Leydig cells from adult rat testes by magnetic-activated cell sorting protocol based on prolactin receptor expression., PMID:35735181

The effects of prolactin receptor blockade in a murine endometriosis interna model., PMID:35084123

dPRLR causes differences in immune responses between early and late feathering chickens after ALV-J infection., PMID:34998433

The Potential Prognostic and Therapeutic Implications of Prolactin Receptor and Growth Hormone-releasing Hormone Receptor Expression in Uterine Leiomyosarcomas., PMID:34856572

ABBV-176, a PRLR antibody drug conjugate with a potent DNA-damaging PBD cytotoxin and enhanced activity with PARP inhibition., PMID:34107902

Impairment of testes development in Yangzhou ganders by augmentation of leptin receptor signaling., PMID:34051590

Expression of long-form prolactin receptor is associated with lower disease-free and overall survival in node-negative breast cancer patients., PMID:33633970

Preparation of a Growth Hormone Receptor/Prolactin Receptor Bispecific Antibody Antagonist Which Exhibited Anti-Cancer Activity., PMID:33362552

Phase I Study of LFA102 in Patients With Advanced Breast Cancer or Castration-resistant Prostate Cancer., PMID:32878811

COMMD8 changes expression during initial phase of wasp venom immunotherapy., PMID:32559011

A first-in-human, phase 1, dose-escalation study of ABBV-176, an antibody-drug conjugate targeting the prolactin receptor, in patients with advanced solid tumors., PMID:32524319

A novel bispecific antibody targeting CD3 and prolactin receptor (PRLR) against PRLR-expression breast cancer., PMID:32398042

α-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by α-TGFβ antibody to promote durable rejection and immunity in squamous cell carcinomas., PMID:30832732

Effects of Dietary Daidzein Supplementation on Reproductive Performance, Serum Hormones, and Reproductive-Related Genes in Rats., PMID:29899203

Monoclonal Antibody Against Prolactin Receptor: A Randomized Placebo-Controlled Study Evaluating Safety, Tolerability, and Pharmacokinetics of Repeated Subcutaneous Administrations in Postmenopausal Women., PMID:29806538

ImmunoPET Imaging of Endogenous and Transfected Prolactin Receptor Tumor Xenografts., PMID:29684277

Subdomain 2, Not the Transmembrane Domain, Determines the Dimerization Partner of Growth Hormone Receptor and Prolactin Receptor., PMID:28977606

The role of the ovarian cycle and the effects of mitogen-induced cytokines on human prolactin gene expression in peripheral blood mononuclear cells., PMID:28972407

Prolactin receptor targeting in breast and prostate cancers: New insights into an old challenge., PMID:28549597

Internal image anti-idiotypic antibody: A new strategy for the development a new category of prolactin receptor (PRLR) antagonist., PMID:28412548

Preclinical Activity of the Novel Anti-Prolactin Receptor (PRLR) Antibody-Drug Conjugate REGN2878-DM1 in PRLR-Positive Breast Cancers., PMID:28377489

Prolactin has a pathogenic role in systemic lupus erythematosus., PMID:28130617

Bispecific Antibodies and Antibody-Drug Conjugates (ADCs) Bridging HER2 and Prolactin Receptor Improve Efficacy of HER2 ADCs., PMID:28108597

Development of a new anti-prolactin receptor (PRLR) antibody, F56, which can serve as a PRLR antagonist., PMID:27829125

Phase I Study of the Prolactin Receptor Antagonist LFA102 in Metastatic Breast and Castration-Resistant Prostate Cancer., PMID:27091421

Development of a Novel, Anti-idiotypic Monoclonal Anti-prolactin Antibody That Mimics the Physiological Functions of Prolactin., PMID:26949959

Role of abnormal anterior pituitary hormones-growth hormone and prolactin in active systemic lupus erythematosus., PMID:26770558

Different intracellular signalling pathways triggered by an anti-prolactin receptor (PRLR) antibody: Implication for a signal-specific PRLR agonist., PMID:26526176

A Neutralizing Prolactin Receptor Antibody Whose In Vivo Application Mimics the Phenotype of Female Prolactin Receptor-Deficient Mice., PMID:26284426

The prolactin receptor as a therapeutic target in human diseases: browsing new potential indications., PMID:26063597

A genome-wide association study for clinical mastitis in first parity US Holstein cows using single-step approach and genomic matrix re-weighting procedure., PMID:25658712

Prolactin-induced prostate tumorigenesis., PMID:25472541

Molecular pathways: blockade of the PRLR signaling pathway as a novel antihormonal approach for the treatment of breast and prostate cancer., PMID:23515410

Neutralization of prolactin receptor function by monoclonal antibody LFA102, a novel potential therapeutic for the treatment of breast cancer., PMID:23270929

The role of prolactin receptor in GH signaling in breast cancer cells., PMID:23192981

Autocrine prolactin induced by the Pten-Akt pathway is required for lactation initiation and provides a direct link between the Akt and Stat5 pathways., PMID:23028142

Distribution of prolactin receptors suggests an intraductal role for prolactin in the mouse and human mammary gland, a finding supported by analysis of signaling in polarized monolayer cultures., PMID:22081226

Prolactin plays a stimulatory role in ovarian follicular development and egg laying in chicken hens., PMID:21600726

Growth hormone signaling in human T47D breast cancer cells: potential role for a growth hormone receptor-prolactin receptor complex., PMID:21310852

Heat stress abatement during the dry period influences metabolic gene expression and improves immune status in the transition period of dairy cows., PMID:21183020

Characterization of ductal and lobular breast carcinomas using novel prolactin receptor isoform specific antibodies., PMID:21144038

Datasheet
$ 372
Product specifications
100 μg 372 1 mg 1486

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

InVivoMAb Anti-Human PRLR Antibody (Iv0132) [VHD18001]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only